Innovative Development of Bio-Pharmaceutical Industry in Liaoning 
Province from the Perspective of Patent Data

Asian Journal of Social Pharmacy ›› 2019, Vol. 14 ›› Issue (4): 174-184.

Previous Articles Next Articles

Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data

Wu Yakun, Yuan Hongmei*

School of Business Administration, Shenyang Pharmaceutical University(Shenyang 110016, China

Online:2019-12-20 Published:2019-12-19
Contact: Yuan Hongmei, professor. Major research area: intellectual property rights of pharmaceutical, etc. Tel: 024- 23986553, E-mail: yuanhm612@163.com. E-mail:yuanhm612@163.com

Abstract

Abstract: Objective To study the innovation and cooperation of bio-pharmaceutical industry in Liaoning Province and to provide some suggestions for the government to formulate innovation policies for the development of this industry. Methods Comparative analysis and social network analysis methods were applied to conduct an empirical analysis of industrial innovative development based on the patent data of bio-pharmaceuticals for nearly 10 years. Results and Conclusion The number of patents in bio-pharmaceutical industry in Liaoning Province is on the rise overall, but it slowed down in recent years. The status of research institutions and universities in innovative cooperation is high, but the overall cooperation among them is relatively loose. In order to promote the innovation and development of bio-pharmaceutical industry in Liaoning, it is necessary to take it as a pillar industry. Meanwhile, importance should be attached to the protection of innovative patents of companies, and industrial clusters should be actively built to promote synergy within the industry

Key words: bio-pharmacy, innovation, patent

Wu Yakun, Yuan Hongmei. Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data[J]. Asian Journal of Social Pharmacy, 2019, 14(4): 174-184.

Trendmd

[1]	Yuan Hongmei, Zhang Wenfeng, Ma Junhong, Zeng Yingying, Meng Lingquan. Research on the Identification of Core Technologies of China’s Pharmaceutical Cold Chain Based on Patent Analysis [J]. Asian Journal of Social Pharmacy, 2021, 16(2): 128-138.
[2]	Wu Tong, Dong Li. Analysis on the Development Trend and Countermeasures of Clopidogrel [J]. Asian Journal of Social Pharmacy, 2021, 16(2): 139-144.
[3]	Ma Junhong, Zhang Wenfeng, Liu Yue, Yuan Hongmei, Zhang Dawei. Research on the Status Quo and Countermeasures of Patent Application in Liaoning Biopharmaceutical Industry Based on Patent Map [J]. Asian Journal of Social Pharmacy, 2021, 16(2): 145-153.
[4]	Wang Hongwei, Yang Yue. Research and Reference of the Authorized Generic Drug System in the US [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 11-22.
[5]	Zhang Tianqi, Chen Yuwen. Research on the World’s Most Valuable Antihypertensive Drugs Based on Patent Analysis [J]. Asian Journal of Social Pharmacy, 2021, 16(1): 76-83.
[6]	Nie Zewen, Wang Ting, Yuan Hongmei. Analysis of Technological Opportunities in Liaoning Biopharmaceutical Industry from the Perspective of Innovation Subject [J]. Asian Journal of Social Pharmacy, 2020, 15(3): 126-138.
[7]	Zhang Wenfeng, Feng Xin, Yuan Hongmei. Research on Technology Opportunity Identification of Small and Medium-sized Vaccine Enterprises Based on Patent Analysis [J]. Asian Journal of Social Pharmacy, 2020, 15(2): 97-107.
[8]	Zhao Zhe, Sheng Mengdi, Fan Junyan, Liu Yanwen, Dong Li. Patent Applications of Pharmaceutical Industry in Liaoning: Current Situation and Suggestions [J]. Asian Journal of Social Pharmacy, 2019, 14(4): 185-191.
[9]	Hou Chunyang, Yuan Hongmei. The Regulating Effect of Complementary Assets on the Incremental Innovation of Traditional Chinese Medicine Enterprises [J]. Asina Journal Of Social Pharmacy, 2019, 14(2): 45-54.
[10]	Huang Yufeng, Luo Suping, Yuan Hongmei. Research on Drug-Patent Linkage System under the New Situation [J]. Asina Journal Of Social Pharmacy, 2019, 14(1): 7-14.
[11]	Ding Wenqing, Luo Suping, Yuan Hongmei, Zhang Dawei. Research on Protection of the Interests of Generic Drug Companies in the Drug-Patent Linkage System Based on Cournot Model [J]. Asina Journal Of Social Pharmacy, 2019, 14(1): 15-20.
[12]	Jin Quanyuan, Lin Xiaohui, Dong Li. Patent Early Warning Mechanism in Pharmaceutical Universities in China [J]. Asina Journal Of Social Pharmacy, 2018, 13(3): 86-92.
[13]	Dong Xinyue, Feng Chong, Yuan Hongmei. Analysis of Enterprise Performance Based on Inheritance and Innovation [J]. Asina Journal Of Social Pharmacy, 2018, 13(2): 45-55.
[14]	Jin Quanyuan, Lin Xiaohui, Dong Li. Research on Setting up Patent Risk Management System in Medical colleges and universities in China [J]. Asina Journal Of Social Pharmacy, 2018, 13(1): 8-15.
[15]	Alita, Wu Zhi’ang. A Study of the International Collaboration Network in Pharmaceutical Research in the United States [J]. Asina Journal Of Social Pharmacy, 2017, 12(4): 131-139.

Asian Journal Of Social Pharmacy

Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments